Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 04 2019 - 7:00AM
Sientra, Inc. (NASDAQ:SIEN) ( “Sientra” or the “Company”), a
medical aesthetics company, today announced that on May 30, 2019,
the Compensation Committee of the Company’s Board of Directors
approved equity award grants under the Sientra, Inc. Inducement
Plan to 17 new employees.
The new employees were granted restricted stock units
representing a total of 89,067 shares of common stock. The
restricted stock units will vest in three equal annual installments
beginning on each individual employee’s hiring date. In each case,
the vesting of shares is contingent upon the individual’s continued
employment with the Company through each vesting date.
The grants were made as an inducement that was a material
component of each person’s compensation and subsequent acceptance
of employment with the Company or joining Sientra’s subsidiary,
miraDry, Inc., and were granted as an employment inducement award
pursuant to NASDAQ Listing Rule 5635(c)(4) approved by the
Compensation Committee.
About SientraHeadquartered in Santa Barbara,
California, Sientra is a diversified global medical aesthetics
company and a leading partner to aesthetic physicians. The Company
offers a suite of products designed to make a difference in
patients' lives by enhancing their body image, growing their
self-esteem, and restoring their confidence. Sientra has developed
a broad portfolio of products with technologically differentiated
characteristics, supported by independent laboratory testing and
strong clinical trial outcomes. The Company’s Breast Products
Segment includes its OPUS™ breast implants, the first fifth
generation breast implants approved by the FDA for sale in the
United States, its ground-breaking Allox2® breast tissue expander
with patented dual-port and integral drain technology, and
BIOCORNEUM® the #1 performing, preferred and recommended scar gel
of plastic surgeons(*). The Company’s miraDry Segment, comprises
its miraDry® system, which is approved for sale in over 40
international markets, and is the only non-surgical FDA-cleared
device for the permanent reduction of underarm sweat, odor and hair
of all colors.
(*) Data on file
Investor Contact:
Neil Bhalodkar
(805) 679-8845
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Apr 2023 to Apr 2024